Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after multiple subcutaneous doses in healthy subjects
Authors:
- Wojciech KrzyzanskiWKWojciech Krzyzanski
- William J. JuskoWJWilliam J. Jusko
- Mary C. WacholtzMWMary C. Wacholtz
- Neil MintonNMNeil Minton
- Wing K. CheungWCWing K. Cheung
- 1 November 2005
- journal article
- clinical trial
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 26 (3-4) , 295-306
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Pharmacokinetic analysis of subcutaneous erythropoietin administration with nonlinear mixed effect model including endogenous productionBritish Journal of Clinical Pharmacology, 1998
- Erythropoietin-the first 90 yearsClinical and Laboratory Haematology, 1996
- rh‐Erythropoietin stimulates immature reticulocyte release in manBritish Journal of Haematology, 1994
- Comparison of four basic models of indirect pharmacodynamic responsesJournal of Pharmacokinetics and Biopharmaceutics, 1993
- Erythropoietin for anaemia in cancer patientsEuropean Journal of Cancer, 1993
- The molecular mechanism of erythropoietin actionEuropean Journal of Biochemistry, 1992
- Clinical Pharmacokinetics of Epoetin (Recombinant Human Erythropoietin)Clinical Pharmacokinetics, 1991
- Erythropoietin Treatment of Anemia Associated with Multiple MyelomaNew England Journal of Medicine, 1990
- A program package for simulation and parameter estimation in pharmacokinetic systemsComputer Programs in Biomedicine, 1979
- A new look at the statistical model identificationIEEE Transactions on Automatic Control, 1974